Moderna announced an increase in stock following first-quarter earnings reported that its only commercially available Covid vaccine exceeded estimates. The results come slightly before the biotech company plans
Moderna says their newest Covid vaccine is showing signs of stronger immune response against the virus than the current shot being offered – and longer shelf-life. Approximately 11,400